REG - EMIS Group PLC - De-listing and cancellation of trading

NumisAnnouncement

30/10/2023 08:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231030:nRSd6883Ra&default-theme=true

RNS Number : 6883R  EMIS Group PLC  30 October 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

30 October 2023

RECOMMENDED CASH ACQUISITION

OF

EMIS GROUP PLC ("EMIS")

BY

BORDEAUX UK HOLDINGS II LIMITED ("Bidco")

an affiliate of

Optum Health Solutions (UK) Limited ("oPTUM uk")

and a wholly owned subsidiary of

UnitedHealth Group Incorporated ("unitedhealth group")

DE-LISTING AND CANCELLATION OF TRADING OF EMIS SHARES

Further to the announcement made by the Boards of EMIS and Bidco on 27 October
2023 that the Scheme has become Effective, the Boards of EMIS and Bidco
announce that, following an application by EMIS, the London Stock Exchange has
cancelled the listing of EMIS Shares on AIM and has cancelled the trading of
EMIS Shares on the London Stock Exchange's AIM Market, in each case with
effect from 7.00 a.m. (London time) today, 30 October 2023.

Defined terms used but not defined in this announcement have the meanings set
out in the scheme document sent to EMIS Shareholders dated 8 July 2022.

Enquiries:

 EMIS
 Andy Thorburn, Chief Executive Officer                                        +44 0330 024 1269
 Peter Southby, Chief Financial Officer

 Deutsche Numis (Financial adviser, corporate broker and nominated adviser to
 EMIS)
 Simon Willis                                                                  +44 (0) 207 260 1000
 Joshua Hughes
 Havish Patel

 MHP (PR adviser to EMIS)                                                      +44 (0) 203 128 8100
 Reg Hoare                                                                     EMIS@mhpgroup.com
 Ollie Hoare
 Matthew Taylor

 Bidco / Optum UK
 Aisling Kearney                                                               +44 7971 428266

 Robey Warshaw (Financial Adviser to UnitedHealth Group and Bidco)
 Simon Warshaw                                                                 +44 20 7317 3900
 Philip Apostolides

 FGS Global (PR Adviser to Bidco and Optum UK)
 John Gray                                                                     +44 20 7251 3801
 Amanda Healy                                                                  Optum-LON@fgsglobal.com

 

Travers Smith LLP are retained as legal adviser to EMIS and Slaughter &
May are retained as legal adviser to Bidco and UnitedHealth Group.

Important notices

Robey Warshaw, which is authorised and regulated by the FCA in the UK, is
acting exclusively for UnitedHealth Group and Bidco and no one else in
connection with the Acquisition and will not be responsible to anyone other
than UnitedHealth Group and Bidco for providing the protections afforded to
clients of Robey Warshaw or for providing advice in relation to the
Acquisition or any other matters referred to in this announcement.

Numis Securities Limited ("Deutsche Numis"), which is authorised and regulated
by the FCA in the UK, is acting exclusively for EMIS and no one else in
connection with the Acquisition or any other matters referred to in this
announcement and will not be responsible to anyone other than EMIS for
providing the protections afforded to clients of Deutsche Numis or for
providing advice in relation to the Acquisition or any other matters referred
to in this announcement. Neither Deutsche Numis nor any of its affiliates,
directors or employees owes or accepts any duty, liability or responsibility
whatsoever (whether direct or indirect, consequential, whether in contract, in
tort, in delict, under statute or otherwise) to any person who is not a client
of Deutsche Numis in connection with the Acquisition, any statement contained
herein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFDFSWSEDSELS